BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24247573)

  • 21. Canine cutaneous epitheliotropic lymphoma (mycosis fungoides) is a proliferative disorder of CD8+ T cells.
    Moore PF; Olivry T; Naydan D
    Am J Pathol; 1994 Feb; 144(2):421-9. PubMed ID: 7906096
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low CD7 expression in benign and malignant cutaneous lymphocytic infiltrates: experience with an antibody reactive with paraffin-embedded tissue.
    Murphy M; Fullen D; Carlson JA
    Am J Dermatopathol; 2002 Feb; 24(1):6-16. PubMed ID: 11803274
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mycosis fungoides in patients under 20 years of age: report of 7 cases, review of the literature and study of the clinical course.
    Quaglino P; Zaccagna A; Verrone A; Dardano F; Bernengo MG
    Dermatology; 1999; 199(1):8-14. PubMed ID: 10449950
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness (or lack thereof) of immunophenotyping in atypical cutaneous T-cell infiltrates.
    Florell SR; Cessna M; Lundell RB; Boucher KM; Bowen GM; Harris RM; Petersen MJ; Zone JJ; Tripp S; Perkins SL
    Am J Clin Pathol; 2006 May; 125(5):727-36. PubMed ID: 16707374
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The expression of CXCR3 and CD30 in mycosis fungoides.
    Nikoo A
    Arch Iran Med; 2012 Mar; 15(3):146-50. PubMed ID: 22369302
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gamma-Delta and CD20 Mycosis Fungoides: Two Cases Uncovered by Broad-Spectrum Immunostaining.
    Patel P; Fraga GR
    Am J Dermatopathol; 2021 Dec; 43(12):950-954. PubMed ID: 34797791
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CD3 and CD20 Coexpression in a Case of Canine Cutaneous Epitheliotropic T-Cell Lymphoma (Mycosis Fungoides).
    Brachelente C; Affolter VK; Fondati A; Porcellato I; Sforna M; Lepri E; Mechelli L; Bongiovanni L
    Vet Pathol; 2016 May; 53(3):563-6. PubMed ID: 26354309
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Mycosis fungoides associated with B-cell malignancies.
    Barzilai A; Trau H; David M; Feinmesser M; Bergman R; Shpiro D; Schiby G; Rosenblatt K; Or R; Hodak E
    Br J Dermatol; 2006 Aug; 155(2):379-86. PubMed ID: 16882178
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mycosis fungoides/Sézary syndrome: report of an unusual case.
    Mehta A; Dhungel BM; Khan MF
    J Cutan Pathol; 2006 Sep; 33 Suppl 2():12-5. PubMed ID: 16972946
    [TBL] [Abstract][Full Text] [Related]  

  • 30. CD45RA+ immunophenotype in mycosis fungoides: clinical, histological and immunophenotypical features in 22 patients.
    Fierro MT; Novelli M; Savoia P; Cambieri I; Quaglino P; Osella-Abate S; Bernengo MG
    J Cutan Pathol; 2001 Aug; 28(7):356-62. PubMed ID: 11437941
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hypopigmented mycosis fungoides in childhood and adolescence: a long-term retrospective study.
    Castano E; Glick S; Wolgast L; Naeem R; Sunkara J; Elston D; Jacobson M
    J Cutan Pathol; 2013 Nov; 40(11):924-34. PubMed ID: 24320808
    [TBL] [Abstract][Full Text] [Related]  

  • 32. CD4/CD8 double negative mycosis fungoides with PD-1 (CD279) expression--a disease of follicular helper T-cells?
    Kempf W; Kazakov DV; Cipolat C; Kutzner H; Roncador G; Tomasini D
    Am J Dermatopathol; 2012 Oct; 34(7):757-61. PubMed ID: 22722467
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Fas ligand expression by neoplastic T lymphocytes mediates elimination of CD8+ cytotoxic T lymphocytes in mycosis fungoides: a potential mechanism of tumor immune escape?
    Ni X; Hazarika P; Zhang C; Talpur R; Duvic M
    Clin Cancer Res; 2001 Sep; 7(9):2682-92. PubMed ID: 11555580
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Mycosis fungoides in childhood and adolescence with clonal T-cell receptor gamma gene rearrangement. Two cases].
    Krokowski M; Winzer M; Lange K; Thorns C; Gafumbegete E; Feller AC; Merz H
    Hautarzt; 2003 Jun; 54(6):536-40. PubMed ID: 12759739
    [TBL] [Abstract][Full Text] [Related]  

  • 35. CD4/CD8 dual-positive mycosis fungoides: a previously unrecognized variant.
    Knapp CF; Mathew R; Messina JL; Lien MH
    Am J Dermatopathol; 2012 May; 34(3):e37-9. PubMed ID: 22356917
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Overexpression of hypoxia-inducible factor 1 alpha impacts FoxP3 levels in mycosis fungoides--cutaneous T-cell lymphoma: clinical implications.
    Alcántara-Hernández M; Torres-Zárate C; Pérez-Montesinos G; Jurado-Santacruz F; Domínguez-Gómez MA; Peniche-Castellanos A; Ferat-Osorio E; Neri N; Nambo MJ; Alvarado-Cabrero I; Moreno-Lafont M; Huerta-Yepez S; Bonifaz LC
    Int J Cancer; 2014 May; 134(9):2136-45. PubMed ID: 24127318
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The T-cell chemokine receptor CXCR3 is expressed highly in low-grade mycosis fungoides.
    Lu D; Duvic M; Medeiros LJ; Luthra R; Dorfman DM; Jones D
    Am J Clin Pathol; 2001 Mar; 115(3):413-21. PubMed ID: 11242798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hypopigmented interface T-cell dyscrasia: a form of cutaneous T-cell dyscrasia distinct from hypopigmented mycosis fungoides.
    Magro CM; Hagen JW; Crowson AN; Liu YC; Mihm M; Drucker NM; Yassin AH
    J Dermatol; 2014 Jul; 41(7):609-17. PubMed ID: 24806661
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Flow cytometric evaluation of skin biopsies for mycosis fungoides.
    Jokinen CH; Fromm JR; Argenyi ZB; Olerud J; Wood BL; Greisman HA
    Am J Dermatopathol; 2011 Jul; 33(5):483-91. PubMed ID: 21552102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical and pathological spectrum of CD8-positive cutaneous T-cell lymphomas.
    Lu D; Patel KA; Duvic M; Jones D
    J Cutan Pathol; 2002 Sep; 29(8):465-72. PubMed ID: 12207740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.